Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01465490 · ClinicalTrials.gov registry record · Phase 1
Monitoring and Feedback in Substance Abuse Treatment
A Phase 1 study, sponsored by Treatment Research Institute.
- Completed
- Registry status
- Phase 1
- Development phase
- 327
- Enrollment target
NCT01465490: Completed Phase 1 study, sponsored by Treatment Research Institute.
NCT01465490 is a Phase 1 study that has completed, run by Treatment Research Institute. The registered enrollment target is 327 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (445% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01465490, a Phase 1 study, has completed, sponsored by Treatment Research Institute.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 327 participants
- Enrollment target
Study Summary
This is a three-staged study to develop and evaluate a monitoring instrument and associated intervention, as follows: Stage 1 - Develop and determine the reliability, validity, and sensitivity to change of a brief Multidimensional Monitoring Instrument (MMI) for clients in outpatient substance abuse treatment (SAT). Stage 2 - Develop a Monitoring and Feedback Intervention (MFI) that uses the MMI. As part of this process, create a manual, training materials, and competence and adherence measures, and conduct a feasibility study within an outpatient SAT unit to refine the intervention and associated materials and measures. Stage 3 - Conduct a randomized clinical trial (RCT) to determine the preliminary efficacy of the MFI compared to treatment as usual (TAU) for clients in outpatient SAT. In this pilot study, it is hypothesized that the MFI will positively impact the treatment process, and short-term, during treatment, outcomes.
Primary Outcome
Client participant's treatment attendance is obtained from treatment program clinical record.
Interventions
- BEHAVIORAL Monitoring and Feedback Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 327 participants |
| Start Date | 2007-09 |
| Est. Completion | 2011-08 |
| Phase | Phase 1 |
What the finished NCT01465490 record still lists
NCT01465490 is an interventional study that assigns participants to a tested intervention. The registered 327 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (445% higher).
The record links to 0 conditions, and to 1 intervention - of which Monitoring and Feedback Intervention is the first listed.
NCT01465490 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01465490 about?
NCT01465490 is a clinical study titled "Monitoring and Feedback in Substance Abuse Treatment". This is a three-staged study to develop and evaluate a monitoring instrument and associated intervention, as follows: Stage 1 - Develop and determine the reliability, validity, and sensitivity to change of a brief Multidimensional Monitoring Instrument (MMI) for clients in outpatient substance abus...
What is the current status of trial NCT01465490?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 327 participants. The study started on 2007-09. Estimated completion is 2011-08.
What interventions are being tested in trial NCT01465490?
The interventions under investigation include: Monitoring and Feedback Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT01465490?
This trial is sponsored by Treatment Research Institute, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01465490's enrollment target sits among peer trials
327 111th of 2000 higher than 1,890 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04486378 · 327 participants · Phase 2
A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer
- NCT06370182 · 327 participants · NA
Safety and Effectiveness of Mechanical Thrombectomy Using the Anaconda ANA Funnel Catheter
- NCT05156983 · 328 participants · Phase 3
A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent Surgery
- NCT05380401 · 328 participants · NA
Metabolic Mechanisms Induced by Enteral DHA and ARA Supplementation in Preterm Infants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia